Plain-English translation of NCT07573735 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying what happens inside the skin and bloodstream of people with atopic dermatitis (eczema) to better understand why the condition becomes chronic. They believe that damaged skin cells release DNA fragments into the blood, which may activate immune cells in the skin and keep inflammation going. This study will compare these markers in people with eczema to healthy volunteers to see if they could help doctors better diagnose and measure disease severity.
Currently, doctors don't have a clear biological marker to measure how severe eczema is or to predict how the disease will progress. Understanding the immune mechanisms driving chronic eczema inflammation could help develop better treatments and ways to monitor the condition.
You likely qualify if…
You likely don't qualify if…
You would visit the study site for a clinical skin examination and to have blood drawn. If you qualify, researchers may also take a small 4mm skin sample (about the size of a pencil eraser) from an active eczema patch using a punch biopsy tool, which is a quick outpatient procedure. The study is observational, meaning researchers are collecting information rather than giving you a new treatment—they're simply looking at what's already happening in your body.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
China